Voice Therapy for Age-Related Voice Change
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether voice therapy for age-related voice changes is as effective through video calls as it is in person. Participants will receive a specific type of voice therapy called PhoRTE® either via telehealth or face-to-face. The goal is to determine if online therapy can make it easier for seniors to access help with their voice. Seniors who have experienced voice changes and have a device capable of video calls might be suitable for this trial. The findings will help determine if telehealth is a viable alternative for voice therapy, especially as telehealth coverage policies may change. As an unphased trial, this study offers seniors the opportunity to contribute to research that could enhance the accessibility of voice therapy.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What prior data suggests that PhoRTE® therapy is safe for older adults with voice changes?
Research has shown that PhoRTE® therapy is generally easy for patients to handle. Early data indicates that individuals who undergo this voice therapy experience significant improvements in their voice-related quality of life. This suggests the treatment is both effective and safe. Studies have not reported any serious side effects or problems from PhoRTE® therapy, making it a promising and safe option for older adults seeking to improve their voice, whether in person or through telehealth.12345
Why are researchers excited about this trial?
Researchers are excited about PhoRTE® Therapy for age-related voice change because it offers a flexible approach by being available both in-person and via telehealth. Unlike traditional voice therapies that require regular visits to a clinic, the telehealth option allows participants to receive treatment from the comfort of their home, making it more accessible and convenient. This could potentially broaden the reach of effective voice therapy to those who have mobility issues or live in remote areas, without compromising on the quality of care.
What evidence suggests that PhoRTE® therapy is effective for age-related voice change?
Research has shown that Phonation Resistance Training Exercises (PhoRTE®) can greatly improve voice quality in older adults experiencing age-related voice changes. Studies have found that people experience better voice function and quality of life after completing PhoRTE® therapy. This method strengthens the vocal cords and improves vocal endurance, addressing common issues like a weak or hoarse voice. In this trial, participants will receive PhoRTE® therapy either in-person or via telehealth. Early results suggest that both in-person and online PhoRTE® therapy are effective, providing flexibility and accessibility for seniors who need treatment. Overall, PhoRTE® therapy has shown promising results in improving voice quality and patient satisfaction among older adults.
Who Is on the Research Team?
Aaron Rothbart, PhD
Principal Investigator
University of Southern California
Are You a Good Fit for This Trial?
This trial is for adults aged 55 or older experiencing age-related voice changes, such as hoarseness or vocal cord atrophy. Participants must have a diagnosis related to these voice issues and be able to complete therapy sessions either in-person or via telehealth.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive PhoRTE® voice therapy either in-person or via telehealth, consisting of four 45-minute sessions conducted at weekly or biweekly intervals.
Follow-up
Participants are monitored for improvements in voice function and quality of life through various assessments.
What Are the Treatments Tested in This Trial?
Interventions
- PhoRTE® Therapy
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Southern California
Lead Sponsor